About EIP Pharma
EIP Pharma is a private company based in Boston, Massachusetts, incorporated in 2018 in Delaware. It has reported $44,118,499 raised in six offerings on Form D since April 2018. Its chief executive is John Alam.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 10, 2023 | Jul 20, 2023 | $810,000fully sold | 2 | $405K | EquityRule 506(b) | Form D ↗ |
| Dec 10, 2021 | Dec 23, 2021 | $6,000,000of $10.0M target | 3 | $2.0M | DebtRule 506(b) | Form D ↗ |
| Dec 4, 2020 | Jan 15, 2021 | $5,078,500of $10.0M target | 28 | $181K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 9, 2020 | Jan 23, 2020 | $2,730,000of $4.5M target | 6 | $455K | EquityRule 506(b) | Form D ↗ |
| Dec 12, 2018 | Dec 19, 2018 | $9,000,000of $12.5M target | 4 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Apr 2, 2018 | Apr 13, 2018 | $20,499,999fully sold | 3 | $6.8M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, six offerings | $44,118,499 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EIP Pharma's Form D filed Jul 20, 2023.
JP
Jeff Poulton
Director
WT
William Turner
Executive officer
SG
Sylvie Gregoire
Director
FZ
Frank Zavrl
Director
KB
Kelly Blackburn
Executive officer
JA
John Alam
CEO and director
MS
Marwan Sabbagh
Director
Earlier filings also listed Tatjana May (director, last listed Jan 2021) and Noel Donnelly (chief financial officer, last listed Jan 2021).